Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
11 - 17 of 17 search results for neuroscience |u:www.enterprise.cam.ac.uk

  1. Fully-matching results

  2. Astellas announces acquisition of Cambridge spin-out Quethera –…

    https://www.enterprise.cam.ac.uk/news/astellas-announces-acquisition-of-cambridge-spin-out-quethera/
    Thumbnail for Astellas announces acquisition of Cambridge spin-out Quethera – Cambridge Enterprise 23 Oct 2020: Quethera was co-founded in 2013 by Dr Peter Widdowson and Professor Keith Martin (Professor and Head of Ophthalmology, Department of Clinical Neurosciences, University of Cambridge).

  3. Cambridge drug approved for treatment of multiple sclerosis –…

    https://www.enterprise.cam.ac.uk/news/drug-developed-in-cambridge-approved-for-treatment-of-multiple-sclerosis/
    Thumbnail for Cambridge drug approved for treatment of multiple sclerosis – Cambridge Enterprise 23 Oct 2020: In 1991, Alastair Compston (Professor of Neurology and Head of the Department of Clinical Neurosciences) began to explore the use of Alemtuzumab as a treatment for the autoimmune disease MS. ... Dr Coles, from the Department of Clinical Neurosciences,

  4. 'Brain training’ app may improve memory and daily functioning in…

    https://www.enterprise.cam.ac.uk/news/brain-training-app-may-improve-memory-and-daily-functioning-in-schizophrenia/
    Thumbnail for 'Brain training’ app may improve memory and daily functioning in schizophrenia – Cambridge Enterprise 23 Oct 2020: State-of-the-art neuroscience at the University of Cambridge, combined with the innovative approach at Peak, will help bring the games industry to a new level and promote the benefits ... The impact of neuroscience on society: Cognitive enhancement in

  5. FDA approves MS drug developed by University of Cambridge researchers …

    https://www.enterprise.cam.ac.uk/news/fda-approves-ms-drug-developed-by-university-of-cambridge-researchers/
    Thumbnail for FDA approves MS drug developed by University of Cambridge researchers – Cambridge Enterprise 23 Oct 2020: Campath-1H was identified as a potential treatment for multiple sclerosis by Professor Alastair Compston, Professor of Neurology and Head of the Department of Clinical Neurosciences, in the late 1980s.

  6. New treatment for multiple sclerosis – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/new-treatment-for-multiple-sclerosis-cambridge-university-translates-research-at-the-bench-into-a-drug-at-the-bedside/
    Thumbnail for New treatment for multiple sclerosis – Cambridge Enterprise 23 Oct 2020: In 1991, Professor Alastair Compston (current Head of the Department of Clinical Neurosciences) began to explore the use of alemtuzumab as a treatment for the autoimmune disease multiple sclerosis.

  7. Improving cognitive testing on animals to treat human disorders –…

    https://www.enterprise.cam.ac.uk/case-studies/improving-cognitive-testing-on-animals-to-develop-drugs-to-treat-human-disorders/
    Thumbnail for Improving cognitive testing on animals to treat human disorders – Cambridge Enterprise 27 Nov 2020: Campden Instruments contributed to the proliferation of the science by organising touchscreen seminars at the Society for Neuroscience meeting, and supporting a symposium.

  8. Quethera announces financing for gene therapy to prevent blindness in …

    https://www.enterprise.cam.ac.uk/news/quethera-announces-seed-financing-to-develop-gene-therapy-aimed-at-preventing-blindness-in-glaucoma-patients/
    Thumbnail for Quethera announces financing for gene therapy to prevent blindness in glaucoma patients – Cambridge Enterprise 23 Oct 2020: of Clinical Neurosciences, who is also a Quethera founder.

Refine your results

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.